The Neuroendocrine Role of Oxytocinergic Pathways in Obesity

Area of Science:

• Neuroendocrinology
• Metabolic Disorders
• Pharmacology

Background:

• Oxytocin (OXT) and its neuronal system are implicated in regulating body weight and metabolism.
• Preclinical data suggest OXT's potential for obesity treatment via appetite suppression, increased energy expenditure, and lipolysis.
• Clinical translation of OXT for obesity is limited by inconsistent trial results and safety/dosing concerns.

Purpose of the Study:

• To review the therapeutic potential of oxytocin for obesity and related metabolic disorders.
• To identify challenges hindering the clinical application of oxytocin in obesity management.
• To highlight future research directions for optimizing oxytocin-based therapies.

Main Methods:

• Literature review of preclinical and clinical studies on oxytocin's role in metabolic regulation.
• Analysis of neuroendocrine mechanisms underlying oxytocin's effects on food intake and energy balance.
• Evaluation of safety and efficacy data from oxytocin trials for obesity.

Main Results:

• Preclinical evidence strongly supports oxytocin's efficacy in promoting weight loss through multiple pathways.
• Clinical studies show variable outcomes, indicating a need for refined therapeutic strategies.
• Key challenges include managing long-term safety and achieving precise dose control.

Conclusions:

• Oxytocin presents a significant therapeutic avenue for obesity and metabolic diseases.
• Further research is crucial to understand oxytocin's neuroendocrine actions and develop targeted modulation strategies.
• Overcoming clinical translation hurdles is essential for realizing safe and effective oxytocin-based obesity treatments.